We are live on ! Find out more
SCM

Sterling Capital Management Portfolio holdings

AUM $5.9B
1-Year Est. Return 29.63%
This Fund
S&P 500
This Quarter Est. Return
+17.46%
1 Year Est. Return
+29.63%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$5.9B
AUM Growth
+$620M
Cap. Flow
-$8.35M
Cap. Flow %
-0.14%
Top 10 Hldgs %
23.55%
Holding
3,465
New
250
Increased
687
Reduced
2,249
Closed
176

Top Sells

Rank Stock Value
1
MRVL icon
Marvell Technology
MRVL
+$47.2M
2
MSFT icon
Microsoft
MSFT
+$38.2M
3
AAPL icon
Apple
AAPL
+$37M
4
AMZN icon
Amazon
AMZN
+$35.5M
5
CTRA
Coterra Energy
CTRA
+$34.4M

Sector Composition

Rank Sector Weight
1 Miscellaneous 21.44%
2 Technology 20.51%
3 Financials 13.46%
4 Industrials 10.73%
5 Healthcare 7.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ELMT
3101
The Elmet Group
ELMT
$516M
$691 ﹤0.01%
+35
New +$601
STRW icon
3102
Strawberry Fields REIT
STRW
$194M
$688 ﹤0.01%
50
-17
-25% -$221
SRZN icon
3103
Surrozen
SRZN
$243M
$675 ﹤0.01%
+26
New +$714
KRMD icon
3104
KORU Medical Systems
KRMD
$146M
$664 ﹤0.01%
158
-123
-44% -$504
CURI icon
3105
CuriosityStream
CURI
$157M
$662 ﹤0.01%
249
-107
-30% -$316
VHI icon
3106
Valhi
VHI
$528M
$660 ﹤0.01%
45
-35
-44% -$494
INFU icon
3107
InfuSystem Holdings
INFU
$237M
$656 ﹤0.01%
+68
New +$645
RAIL icon
3108
FreightCar America
RAIL
$241M
$653 ﹤0.01%
+67
New +$564
NAGE
3109
Niagen Bioscience
NAGE
$245M
$648 ﹤0.01%
203
-136
-40% -$552
TAYD icon
3110
Taylor Devices
TAYD
$198M
$645 ﹤0.01%
+11
New +$595
UNCY icon
3111
Unicycive Therapeutics
UNCY
$140M
$633 ﹤0.01%
+135
New +$996
FHTX icon
3112
Foghorn Therapeutics
FHTX
$287M
$625 ﹤0.01%
128
-360
-74% -$1.6K
RFIL icon
3113
RF Industries
RFIL
$115M
$615 ﹤0.01%
+29
New +$469
NMRA icon
3114
Neumora Therapeutics
NMRA
$235M
$612 ﹤0.01%
+360
New +$685
PLX icon
3115
Protalix BioTherapeutics
PLX
$214M
$606 ﹤0.01%
260
-193
-43% -$409
OBIO icon
3116
Orchestra BioMed
OBIO
$326M
$604 ﹤0.01%
+140
New +$573
EVMN
3117
Evommune Inc
EVMN
$475M
$598 ﹤0.01%
45
-155
-78% -$3.6K
LWAY icon
3118
Lifeway Foods
LWAY
$377M
$597 ﹤0.01%
20
-13
-39% -$331
SVCO
3119
Silvaco Group
SVCO
$229M
$593 ﹤0.01%
43
-225
-84% -$2.34K
FJET
3120
Starfighters Space Inc
FJET
$145M
$575 ﹤0.01%
+108
New +$646
MKTW icon
3121
MarketWise
MKTW
$50.7M
$571 ﹤0.01%
32
-33
-51% -$569
GLSI icon
3122
Greenwich LifeSciences
GLSI
$233M
$563 ﹤0.01%
24
-16
-40% -$389
VATE icon
3123
INNOVATE Corp
VATE
$95.9M
$560 ﹤0.01%
+30
New +$407
LUCD icon
3124
Lucid Diagnostics
LUCD
$171M
$559 ﹤0.01%
522
-1,378
-73% -$1.49K
ESP icon
3125
Espey Mfg & Electronics Corp
ESP
$189M
$539 ﹤0.01%
+8
New +$507

Similar funds

Sterling Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, Sterling Capital Management held 3,465 positions worth $5.9B, up 12% from $5.28B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Sterling Capital Management's Q2 2026 filing shows 250 new, 687 increased, 2,249 reduced and 176 closed positions. Its largest new stake was Coca-Cola Europacific Partners: 217,119 shares worth $21.7M. The largest sale was Marvell Technology, an estimated $47.2M.

By sector, the portfolio is most concentrated in Miscellaneous at 21% of assets, up from 17% a quarter earlier, followed by Technology and Financials.

  • Sterling Capital Management's largest Q2 2026 buy was Coca-Cola Europacific Partners: 217,119 shares worth $21.7M.
  • Sterling Capital Management added most to Philip Morris in Q2 2026, an estimated $43.1M increase.
  • Sterling Capital Management's biggest Q2 2026 reduction was Marvell Technology, cutting an estimated $47.2M.
  • Sterling Capital Management fully exited Coterra Energy in Q2 2026, selling an estimated $34.4M.
  • Sterling Capital Management's ten largest holdings make up 24% of its $5.9B portfolio in Q2 2026.
  • Sterling Capital Management opened 250 new positions and closed 176 in Q2 2026.
  • Sterling Capital Management's portfolio value rose 12% quarter-over-quarter to $5.9B.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.